In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

2021 ESC/EACTS Guidelines for the management of valvular heart disease

ESC Clinical Practice Guidelines

Decision-making in VHD involves accurate diagnosis, timing of intervention, risk assessment and, based on these, selection of the most suitable type of intervention. These guidelines focus on acquired VHD, are oriented towards management, and do not deal with endocarditis, congenital valve disease (including pulmonary valve disease), or recommendations concerning sports cardiology and exercise in patients with cardiovascular disease, as separate guidelines have been published by the ESC on these topics.

Valvular Heart Disease

Main resources

Full text and related materials

Full text


Published on 18 February 2022

Declarations of interest

Read the full text

Scientific Presentation at ESC Congress 2021

Relive the presentation as it was live.

Watch now

More resources

ESC TV Interview

The essentials of the Guidelines in less than four minutes.

Congress News Article

Insights from the Chairs of the Guidelines Task Force.

Slide set

Educational material.

ESC Cardio Talk

With Friedhelm Beyersdorf, from Germany and Alec Vahanian, from France